Thrombophilic disorders and fetal loss: a meta-analysis
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Background Our aim was to assess the strength of the controversial association between thrombophilia and fetal loss, and to examine whether it varies according to the timing or definition of fetal loss.Methods We searched Medline and Current Contents for articles published between 1975 and 2002 and their references with terms denoting recurrent fetal and non-recurrent fetal loss combined with various thrombophilic disorders. We included in our meta-analysis case-control, cohort, and cross-sectional studies published in English, the methodological quality of which was rated as moderate or strong. Pooled odds ratios (OR) with 95% CI were generated by random effects models with Cochrane Review Manager software.Findings We included 31 studies. Factor V Leiden was associated with early (OR 2.01, 95% CI 1.13-3.58) and late (7.83, 2.83-21.67) recurrent fetal loss, and late non-recurrent fetal loss (3.26, 1.82-5.83). Exclusion of women with other pathologies that could explain fetal loss strengthened the association between Factor V Leiden and recurrent fetal loss. Activated protein C resistance was associated with early recurrent fetal loss (3.48, 1.58-7.69), and prothrombin G20210A mutation with early recurrent (2.56, 1.04-.29) and late non-recurrent (2.30, 1.09-4.87) fetal loss. Protein S deficiency was associated with recurrent fetal loss (14.72, 0.99-218.01) and late non-recurrent fetal loss (7.39, 1.28-42.63). Methylenetetrahydrofolate mutation, protein C, and antithrombin deficiencies were not significantly associated with fetal loss.Interpretation The magnitude of the association between thrombophilia and fetal loss varies, according to type of fetal loss and type of thrombophilia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Factor V Leiden appears to be associated with first and particularly second trimester recurrent miscarriages.41,43”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [41]
In the citing paper
“Meta-analyses of pooled data suggest that the magnitude of the association between inherited thrombophilias and fetal loss varies according to the type of thrombophilia, timing of fetal loss, maternal ethnicity and maternal age.”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [41]
In the citing paper
“It is generally recognised that there is a stronger and more consistent association between second trimester miscarriages and inherited thrombophilias.41,42”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [41]
In the citing paper
“Protein C deficiency has not shown a consistent association with recurrent miscarriage.41,44”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [41]
In the citing paper
“Prothrombin gene mutation is associated with recurrent miscarriage.[41][42][43]”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [41]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy
Kupferminc, M. J., Eldor, A., Steinman, N., Many, A., Bar-Am, A., Jaffa, A., Fait, G., & Lessing, J. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400102 · Cited by 956
Increased frequency of genetic thrombophilia in women with complications of pregnancy
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80075-3 · Cited by 832
Genetic Susceptibility to Venous Thrombosis
Seligsohn, U., & Lubetsky, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441607 · Cited by 822
Increased fetal loss in women with heritable thrombophilia
Preston, F., Rosendaal, F., Walker, I., Briët, E., Berntorp, E., Conard, J., Fontcuberta, J., Makris, M., Mariani, G., Noteboom, W., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04125-6 · Cited by 661
(1992) · PubMed · Cited by 434
How strong is the association between maternal thrombophilia and adverse pregnancy outcome?
Alfirevic, Z., Roberts, D., & Martlew, V. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00496-1 · Cited by 339
de Visser, M. C. H., Rosendaal, F. R., & Bertina, R. M. (1999) · Blood · doi:10.1182/blood.v93.4.1271 · Cited by 308
Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis
Nelen, W. L. D. M., Blom, H. J., Steegers, E. A. P., den Heijer, M., & Eskes, T. K. A. B. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01595-8 · Cited by 304
Mutations in Coagulation Factors in Women with Unexplained Late Fetal Loss
Martinelli, I., Taioli, E., Cetin, I., Marinoni, A., Gerosa, S., Villa, M. V., Bozzo, M., & Mannucci, P. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431405 · Cited by 304
Cited by
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Rai, R., & Regan, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69204-0 · Cited by 1,227
Thrombophilia in pregnancy: a systematic review
Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G. D. O., Walker, I. D., Greaves, M., Brenkel, I., Regan, L., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05847.x · Cited by 849
Recurrent pregnancy loss: etiology, diagnosis, and therapy.
Ford, H., & Schust, D. J. (2009) · PubMed · Cited by 809
Metadata
- Authors
- Rey, E., Kahn, S. R., David, M., & Shrier, I.
- Affiliations
- Jewish General Hospital (CA)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 361
- Issue
- 9361
- Pages
- 901-908
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2136152362
- Cited by
- 872
- References
- 46
- Citations by year
- 2026: 8 · 2025: 20 · 2024: 12 · 2023: 23 · 2022: 24 · 2021: 22 · 2020: 20 · 2019: 25 · 2018: 25 · 2017: 36 · 2016: 38 · 2015: 27 · 2014: 48 · 2013: 45 · 2012: 50
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- thrombophilia, recurrent pregnancy loss, factor V Leiden, activated protein C resistance, prothrombin G20210A, protein S deficiency, protein C deficiency, antithrombin deficiency
- MeSH terms
- Abortion, Habitual, Factor V, Factor V Deficiency, Female, Humans, Pregnancy, Risk Factors, Prevalence, Thrombophilia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thrombophilic disorders and fetal loss: a meta-analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(03)12771-7
- The paper
- Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003). Thrombophilic disorders and fetal loss: a meta-analysis. The Lancet. https://doi.org/10.1016/s0140-6736(03)12771-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.